NexturnBioscience Co. Ltd (089140) - Total Liabilities

Latest as of September 2025: ₩128.65 Billion KRW ≈ $87.19 Million USD

Based on the latest financial reports, NexturnBioscience Co. Ltd (089140) has total liabilities worth ₩128.65 Billion KRW (≈ $87.19 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore NexturnBioscience Co. Ltd cash conversion from operations to assess how effectively this company generates cash.

NexturnBioscience Co. Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how NexturnBioscience Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 089140 financial resilience to evaluate the company's liquid asset resilience ratio.

NexturnBioscience Co. Ltd Competitors by Total Liabilities

The table below lists competitors of NexturnBioscience Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Daesang Corp Preference Shares KO:001685	Korea	₩2.04 Trillion
Imexhs Ltd AU:IME	Australia	AU$8.36 Million
IVP Limited NSE:IVP	India	Rs1.87 Billion
Citius Pharmaceuticals Inc NASDAQ:CTXR	USA	$46.92 Million
Thai Capital Corporation Public Company Limited BK:TCC	Thailand	฿351.12 Million
Floyd Public Company Limited BK:FLOYD	Thailand	฿176.16 Million
Australian Agricultural Projects Ltd AU:AAP	Australia	AU$8.54 Million
Opus One Resources Inc V:OOR	Canada	CA$812.34K

Liability Composition Analysis (2014–2024)

This chart breaks down NexturnBioscience Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NexturnBioscience Co. Ltd (089140) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.84	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.35	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NexturnBioscience Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NexturnBioscience Co. Ltd (2014–2024)

The table below shows the annual total liabilities of NexturnBioscience Co. Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩96.41 Billion ≈ $65.34 Million	-9.03%
2023-12-31	₩105.98 Billion ≈ $71.82 Million	+15.22%
2022-12-31	₩91.98 Billion ≈ $62.34 Million	+99.04%
2021-12-31	₩46.21 Billion ≈ $31.32 Million	+1689.03%
2020-12-31	₩2.58 Billion ≈ $1.75 Million	-48.45%
2019-12-31	₩5.01 Billion ≈ $3.40 Million	-72.17%
2018-12-31	₩18.01 Billion ≈ $12.20 Million	+502.69%
2017-12-31	₩2.99 Billion ≈ $2.02 Million	-65.43%
2016-12-31	₩8.64 Billion ≈ $5.86 Million	+172.72%
2015-12-31	₩3.17 Billion ≈ $2.15 Million	-28.10%
2014-12-31	₩4.41 Billion ≈ $2.99 Million	--

About NexturnBioscience Co. Ltd

KQ:089140 Korea Machinery, Tools, Heavy Vehicles, Trains & Ships

Market Cap

$15.66 Million

₩23.11 Billion KRW

Market Cap Rank

#25728 Global

#1924 in Korea

Share Price

₩2215.00

Change (1 day)

-0.89%

52-Week Range

₩2060.00 - ₩3170.00

All Time High

₩56500.00